sorafenib has been researched along with Anal Fistula in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gopal, LD; Heller, T; Kohn, EC; von Rosenvinge, EC; Yao, MD | 1 |
1 other study(ies) available for sorafenib and Anal Fistula
Article | Year |
---|---|
Rectal fistulae resulting from treatment with sorafenib and bevacizumab.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzenesulfonates; Bevacizumab; Female; Humans; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Rectal Fistula; Sorafenib | 2009 |